Press Releases

These are news releases that are related to our Investor efforts.  Releases are listed in chronological order and are archived by year.  Sign-up to receive news as it is released using the email and RSS tools below.

 

Archives: Search / 2019 / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008 / 2007 / 2006 / 2005 / 2004 / 2003 / 2002 / 2001 / 2000

2019 Archives

Feb 14, 2019
Perrigo Announces Quarterly Dividend
Feb 13, 2019
Perrigo Announces Patent Litigation Settlement for the Generic Version of Jublia® Topical Solution 10%
Feb 13, 2019
Perrigo Company plc To Release Fourth Quarter And Calendar Year 2018 Results On February 27, 2019
Feb 6, 2019
Perrigo Announces FDA Final Approval for its AB Rated Generic Version of Zovirax® Cream 5%
Jan 29, 2019
Perrigo To Receive Milestone Payment Of $250 Million From RPI Finance Trust
Jan 14, 2019
Perrigo Appoints James Dillard To Role Of Chief Scientific Officer
 

print email rss

Investor Relations

Price Data
NYSEPRGO
Key Contacts
Bradley Joseph
Vice President, Global Investor Relations
269-686-3373
bradley.joseph@perrigo.com